Dear Colleague,
The 2nd Novel Immunotherapeutics Summit taking place on Jan
30 - Feb 1, 2013 in San Diego, brings together experts from academia and industry
to discuss cutting edge research, immuno-strategies and novel therapeutics
against various diseases. Topics such as cytokines, inflammation, cancer
immunotherapy, immunomonitoring, biomarkers, immunosuppression, immunogenicity,
immunotoxicity, allergy and asthma will be discussed at the summit.
The summit
includes the following 4 concurrent tracks as well as an optional pre-summit workshop held on Jan 30, 2013.
2nd Novel Immunotherapeutics Summit:
Workshop:
Immune Responses in
Tumor Microenvironment
Track:
5th Immunotherapeutics & Immunomonitoring
Track:
11th Cytokines & Inflammation
Track:
2nd Allergy & Respiratory Drug Discovery
Track:
Immunogenicity & Immunotoxicity
Network with representatives from prestigious organizations and discuss
the latest research from top leaders in the pharmaceutical and biotech
industries including Abbott, Bristol-Myer-Squibbs, Johnson & Johnson, Janssen
Pharmaceuticals, Sanofi-Aventis, Eli Lilly, Merck, Pfizer, Amgen, Novo Nordisk,
Dendreon, MedImmune, Athersys, Centocor, Elan, Biogen Idec, NIH, FDA, Genzyme,
Harvard Medical School, Stanford University, MD Anderson Cancer Center, UC San
Francisco, and many more!
Click here to register for the
2nd Novel Immunotherapeutics Summit.
Click here to download conference brochure!
Sponsorship and exhibiting opportunities are available, which can be tailored
to fit your needs. Please contact 626-256-6405 x102 or
spex@gtcbio.com for more
information.
See you in San Diego!
Best Regards,
Organizing
Committee
|
|
PLATINUM
SPONSOR |
|
 |
|
|
GOLD
SPONSORS |
|
 |
|
 |
|
 |
|
|
SILVER
SPONSORS |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
Cytokines and Inflammation
WiFi SPONSOR |
 |
|
|
SUPPORTING SPONSOR |
|
 |
|
 |
|
|
MEDIA
PARTNERS |
|
 |
|
 |
| |
 |
| |
What Past Delegates said:
"Energizing and inspiring conference. The new ideas and connections are worth
the investment."
- Francisco Leon, VP, Janssen R&D
"The GTC Meeting provided a unique opportunity for a select group of scientists
from biotechnology, pharmaceutical companies and academia to communicate and
interact in a very pleasant setting. The program covered not only fundamental
advances, but also translational and diagnostic applications of the latest
findings."
- Joost J. Oppenheim Chief of the Laboratory of Molecular Immunoregulation,
Cancer and Inflammation Program, NCI, NIH.
"The GTC Novel Immunotherapeutics Summit was a great opportunity to meet
industry and academic leaders. The networking opportunities were ideal for
meaningful exchanges and setting up potential collaborations. "
- Yoav Peretz Ph.D., Principal Scientist, ImmuneCarta Services
"The GTC conference definitely provided a private, common, and friendly setting
to exchange ideas and opinions with industry and academia leaders. Networking
really happens at this conference with relevant and exciting topics. I left the
GTC conference with fresh ideas and with new connections for future
partnerships. "
- Mario Pulido, USC |
|
